REACT (research)

REACT (research)
Name	REACT
Full name	Real-time Assessment of Community Transmission
Acronym	REACT
Established	2020
Country	United Kingdom
Institutions	Imperial College London; King's College London; University of Oxford; University College London; Public Health England; NHS England
Focus	SARS-CoV-2 surveillance; epidemiology; population seroprevalence
Methods	community testing; polymerase chain reaction; lateral flow assays; household surveys; statistical weighting

REACT (research)

REACT was a large-scale community surveillance programme initiated in 2020 to quantify SARS-CoV-2 prevalence and transmission dynamics across the United Kingdom. It combined mass swab testing, antibody assays, and longitudinal sampling to inform public health policy during the COVID-19 pandemic. The programme produced multiple peer-reviewed analyses that fed into advisory bodies and pandemic response planning.

Background and objectives

REACT was launched amid the global COVID-19 pandemic alongside initiatives such as Imperial College COVID-19 Response Team modelling and the COVID-19 Genomics UK Consortium surveillance effort, seeking to complement hospital-based metrics from NHS England and national statistics from the Office for National Statistics. Primary objectives included estimating community prevalence of active infection using polymerase chain reaction testing, assessing seroprevalence with antibody assays like lateral flow tests used in studies related to Wellcome Trust and National Institute for Health and Care Research priorities, and tracking variants of concern alongside genomic initiatives linked to institutions such as the University of Oxford and University College London. REACT aimed to provide geographically resolved estimates to inform decisions by bodies like the Scientific Advisory Group for Emergencies and the Joint Committee on Vaccination and Immunisation.

Methodology and study design

REACT implemented repeated cross-sectional surveys and cohort follow-up, recruiting participants via postal sampling frames similar to mechanisms used in surveys by the Office for National Statistics and the UK Biobank. Testing modalities combined reverse transcription polymerase chain reaction assays employed in clinical virology laboratories such as those at Public Health England with self-administered lateral flow immunoassays evaluated in collaborations with manufacturers and laboratories linked to King's College London. Sampling stratification matched demographic and geographic strata used by the Census of England and Wales, and statistical weighting borrowed approaches from epidemiological studies at Imperial College London. The design included household surveys, longitudinal repeat sampling, and linkage to vaccination records held by NHS England and to genomic sequencing pipelines coordinated with the COVID-19 Genomics UK Consortium. Quality control procedures referenced standards from Medicines and Healthcare products Regulatory Agency evaluations and assay validation frameworks used in collaborations with Wellcome Sanger Institute.

Key findings and results

REACT produced time series documenting waves of infection that paralleled analyses from the Imperial College COVID-19 Response Team and modelling by teams at London School of Hygiene & Tropical Medicine. Major findings included estimates of community prevalence peaks corresponding to periods identified by national reports from the Office for National Statistics and associations between prevalence and factors highlighted in studies from University of Oxford and King's College London, such as age, household size, and regional variation across England, Scotland, Wales, and Northern Ireland. REACT analyses quantified reductions in transmission following non-pharmaceutical interventions similar to those modelled in publications tied to the MRC Centre for Global Infectious Disease Analysis and evaluated vaccine effectiveness in near-real time alongside work by the National Immunisation Advisory Committee and clinical trials at University College London Hospitals. The programme contributed evidence about variant spread, aligning with genomic observations reported by the COVID-19 Genomics UK Consortium and laboratories including the Wellcome Sanger Institute.

Impact and applications

Findings from REACT informed policy deliberations within advisory forums such as the Scientific Advisory Group for Emergencies and operational responses at Public Health England and NHS England. Data were used by public health bodies to tailor regional interventions and by modelling groups at Imperial College London and London School of Hygiene & Tropical Medicine to calibrate projections for decision-makers including ministers within the Department of Health and Social Care. The surveillance approach influenced international surveillance strategies promoted by organisations like the World Health Organization and fed into evaluations by funders including the National Institute for Health and Care Research and the Wellcome Trust. REACT outputs supported publications in high-profile journals and were cited by national inquiries and reviews of pandemic preparedness, comparable to references used in reports involving the House of Commons Health and Social Care Committee.

Criticisms and controversies

Critiques of REACT mirrored broader debates about surveillance design seen in discussions involving Office for National Statistics methods and academic critiques from groups at University of Cambridge and London School of Hygiene & Tropical Medicine. Concerns raised included representativeness of volunteer samples versus probability samples used in the Census, sensitivity and specificity limitations of lateral flow assays evaluated in studies at King's College London and assay manufacturers, and interpretation of prevalence estimates during rapid epidemic growth similar to controversies faced by the COVID-19 Genomics UK Consortium regarding sequencing coverage. Questions were also posed about timeliness of reporting to decision-makers in comparison with clinical testing streams managed by NHS England and data linkage challenges encountered with administrative systems in the Department of Health and Social Care.

Funding and collaborators

REACT received funding from sources including the National Institute for Health and Care Research, the Wellcome Trust, and institutional support from Imperial College London, King's College London, University of Oxford, and University College London. Collaborators encompassed public health agencies such as Public Health England, genomic partners like the COVID-19 Genomics UK Consortium and the Wellcome Sanger Institute, and clinical and laboratory networks associated with NHS England and university hospitals. The consortium structure paralleled multi-institutional efforts such as the ISARIC network and drew on methodological expertise from groups linked to the MRC Centre for Global Infectious Disease Analysis.

Category:COVID-19 research